Neuronal nicotinic acetylcholine receptors (nAChR) 1 represent important targets for the development of novel drugs for the treatment of pain and various disorders of the central nervous system (1) . To date, eight ␣ and three ␤ subunits (␣2-␣7, ␣9, ␣10, ␤2-␤4) of the nAChRs have been cloned from sensory and neuronal mammalian cells (2) (3) (4) . For the ␣7 and ␣9 subunits, it has been shown that they need no additional subunits to form functional ion channels upon heterologous expression. All other ␣ subunits, however, require at least the co-expression of one ␤ subunit, or another ␣ subunit in the case of ␣10. Ternary combinations of two different ␣ and one ␤ subunit or two different ␤ and one ␣ subunit, and even quaternary combinations have been described (5, 6) . This diversity of subunit combinations has the potential to generate a wide range of receptor subtypes with different pharmacological and functional properties. To help unravel which native neuronal nAChR subunit combinations are responsible for specific physiological functions, additional selective inhibitors are required.
Conotoxins are small disulfide-rich peptides from the venom of the predatory marine snails of the genus Conus. These miniproteins have proved to be valuable tools for investigating the structure and function of ligand-and voltage-gated ion channels. ␣-Conotoxins are competitive antagonists of acetylcholine (ACh) binding to the nAChR (7) . The ␣-conotoxins described so far are among the most selective inhibitors to be identified ( Fig.  1) . They are typically 12-18 amino acids long, contain a conserved Pro in loop I, and are folded by two disulfide bonds connecting Cys 1 -Cys 3 and Cys 2 -Cys 4 . Based on the number of amino acids between the second and third cysteine residues (loop I) and the third and fourth cysteine residues (loop II) they are divided into ␣3/5, ␣4/7, ␣4/6, and ␣4/3 structural subfamilies (8) . The ␣3/5-conotoxins are selective for the muscle-type nAChR, while most ␣4/7-and ␣4/6-conotoxins are selective for neuronal nAChRs. An exception is the ␣4/7-conotoxin EI, which binds to the ␣/␦ interface of the muscle-type nAChR (9) . The ␣4/3-type characterized by ImI is ␣7-selective (10). The threedimensional structures of different neuronal-specific and muscle-specific ␣-conotoxins have been determined by NMR (11) (12) (13) (14) (15) ) and x-ray structural analysis (16 -19) . The ␣4/7-conotoxins and ImI share similar backbone conformations and a rigid hydrophobic core (14) , suggesting that their different specificities for nAChR subtypes arise from the different amino acid side-chains projecting from this conserved scaffold.
The ␣4␤2 nAChRs together with the ␣7 subtype are the most abundant nAChRs in mammalian brain. Knockout studies in mice have revealed an important role for ␣4 and ␤2 in pain and cognition (20) but further investigations of its role are limited by the lack of ␣4␤2-selective inhibitors. A primary goal of this study was to identify new ␣-conotoxins active at the ␣4␤2 subtype. In this report, we describe the isolation and characterization of ␣4/7-conotoxin GID. GID possesses a novel four amino acid N-terminal tail and an Arg in position 12 that contribute to ␣4␤2 selectivity. The NMR structure of GID was determined to define the location of structural features that contribute to the selectivity of GID.
EXPERIMENTAL PROCEDURES

Isolation, Purification, and Sequencing of GID
Extraction of Crude Venom-Nine specimens of Conus geographus were collected from the Great Barrier Reef, Australia. Crude venom duct contents were extracted with 30% acetonitrile/water acidified with 0.1% trifluoroacetic acid and centrifuged. Soluble material (120 mg) was lyophilized and stored at Ϫ20°C prior to use.
Isolation and Purification of GID-A portion of the crude venom extract (40 mg) was fractionated on a semipreparative RP-HPLC column (10-m C 18 , Vydac) eluted at 3 ml/min with a linear gradient of 0 -80% solvent B over 80 min (solvent A, 0.1% trifluoroacetic acid; solvent B, 90% acetonitrile, 0.09% trifluoroacetic acid). Inhibition in a functional nAChR assay (see below) identified an active 1-min fraction eluting at ϳ21 min ( Fig. 2A) , which was further purified by RP-HPLC employing a linear gradient of 0 -25% B over 25 or 45 min (5-m C 18 , 46 ϫ 250 mm Zorbax or Jupiter columns at 1 ml/min or a SB300 3.5 m C 18 , 2.1 ϫ 50 mm Zorbax column at 0.2 ml/min eluted with solvent A, 0.05% trifluoroacetic acid; solvent B, 90% acetonitrile and 0.045% trifluoroacetic acid). An active peptide detected at 214 nm was collected and sequenced after reduction and alkylation with maleimide (see below). Venom was further characterized by LC/MS analysis using a PESciex API QSTAR Pulsar mass spectrometer (m/z 500 -2200) to monitor the eluant from a 5-m C 3 , 2.1 ϫ 150 mm Zorbax column eluted with 0 -60% B over 60 min (A, 0.1% formic acid; B, 90% aqueous acetonitrile, 0.09% formic acid).
Sequencing-The purified peptide (ϳ20 pmol) was reduced in the presence of 10 mM TCEP and 50 mM ammonium acetate, pH 4.5 (37°C for 1 h) before alkylating in the added presence of 20 mM maleimide (37°C for 1 h). The alkylated peptide was repurified by RP-HPLC prior to sequence analysis by Edman chemistry on a 492-01 HT model Procise protein sequencer (see Fig. 1 ). Stock solutions of 100 mM Tris(2-carboxyethyl)-phosphine hydrochloride (Pierce), and maleimide (Aldrich) were prepared in 0.1 M ammonium acetate pH 4.5 and in 10% acetonitrile, respectively, and stored at Ϫ20°C.
Peptide Synthesis
GID and analogues were manually assembled by Boc chemistry, deprotected, and cleaved from resin as described previously (21) . Amino acid side-chain protection was as follows: Arg (Tos), Asn(Xan), Asp(OcHex), Cys(pMeBzl), Gla(OcHex), His (DNP), Hyp(Bzl), and Ser(Bzl). Linear peptides were manually assembled on t-Boc-cysteine-Pam resin, (0.75 mmol substitution/g; Applied Biosystems, Foster City, CA). Double couplings were used where necessary to achieve coupling efficiencies of Ͼ99.5%. HPLC-purified reduced peptides (50 M) were oxidized in 100 mM ammonium bicarbonate at pH 7.5-8 with stirring for 24 -48 h at 23°C. The oxidized peptides were purified by preparative RP-HPLC. The major oxidized product was co-injected with native GID in a 2:1 ratio. Peptides were quantified initially in triplicate by amino acid analysis (22) , then subsequently by RP-HPLC using an external reference standard for each peptide.
Functional Characterization of GID
RNA Preparation-Plasmids containing cDNA encoding rat ␣3, ␣4, ␣7, ␤2, and ␤4 nAChR subunits were provided by J. Patrick (Baylor College of Medicine, Houston, TX) and subcloned into the oocyte expression vector pNKS2 (23) . cDNAs for the mouse ␣1, ␤1, ␥, and ␦ subunits of the muscle nAChR were provided by Dr. V. Witzemann (Max-Planck Institute for Medical Research, Heidelberg, Germany). Capped cRNAs were synthesized from linearized plasmid cDNAs using the Message Machine Kit (Ambion, Austin, TX).
Expression in Xenopus Oocytes-Oocytes were prepared as previously described (24) , injected with 50 nl of cRNA (5-50 ng/l), and kept at 19°C in ND96 (96 mM NaCl, 2 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , and 5 mM Hepes at pH 7.4) supplemented with 50 mg/liter of gentamycin (Sigma Chemical Co.).
Two Electrode Voltage-Clamp Recording-Two electrode voltageclamp recordings were performed in oocytes 2-10 days after cRNA injection at a holding potential of Ϫ70 mV. Pipettes were pulled from borosilicate glass (Harvard Apparatus Ltd., Kent, England) and filled with 3 M KCl. Resistances were below 1 M⍀. Membrane currents were recorded using a two electrode virtual ground circuit on a GeneClamp 500B amplifier (Axon Instruments Inc., Union City, CA), filtered at 200 Hz and digitized at 1 kHz using a Digidata 1322A interface and v8.2 Clampex software (Axon Instruments Inc.). Recordings were performed in ND96 at room temperature. 1 M ACh (Sigma) was used to activate ␣4␤4 and ␣1␤1␥␦ nAChRs, 100 M ACh was used to activate ␣3␤2, ␣3␤4, and ␣4␤2 nAChRs, and 100 M nicotine (Sigma) was used to activate ␣7 nAChR. The perfusion medium was manually switched between ND96 with or without agonist using a Valve Driver II (General Valve Corporation, Fairfield, NJ). A fast and reproducible solution exchange (Ͻ300 ms) for agonist application was achieved using a 50-l funnel-shaped oocyte chamber combined with a fast solution flow (ϳ150 l/s) fed through a custom-made manifold mounted immediately above the oocyte. ACh pulses were applied for 2 s at 6-min intervals. After each application, the cell was superfused for 1 min with agonist-free solution, and the flow was then stopped for 5 min before agonist solution was re-introduced. Peptide was applied when responses to three consecutive agonist applications differed by less than 10%. After the 1-min agonist washout step was stopped, 5.5 l of a 10-fold concentrated peptide solution were pipetted directly into the static bath, mixed by repeated pipetting, and incubated for 5 min prior to application of agonist. Addition of toxin directly to the recording chamber conserved material and avoided potential adhesion of the toxin to tubing surfaces. To obtain estimates of potency, dose-response curves were fitted to the data by the equation percent response ϭ 100/{1 ϩ ([toxin]/IC 50 ) nH } using Prism software (GraphPad v 3.0 for Macintosh, San Diego, CA). To obtain estimates of toxin washout kinetics, agonist responses were measured at 2-min intervals under constant superfusion. For toxin application, oocytes were superfused for 1 min before a 1-min incubation with the toxin followed by the next agonist application.
NMR Solution Structure of GID Sample Preparation-Samples
NMR Spectroscopy-Spectra were obtained on a Bruker DMX 750 spectrometer at 280 and 287 K. All spectra were acquired in phasesensitive mode using TPPI (25) . The homonuclear spectra recorded included double quantum filtered DQF-COSY (26), TOCSY (27) using a MLEV17 spin lock sequence (28) with an isotropic mixing time of 80 ms; ECOSY (29) , and NOESY (30) with mixing times of 150 and 350 ms. In DQF-COSY and ECOSY experiments, the water resonance was suppressed by low power irradiation during the relaxation delay (1.5 s). For the TOCSY and NOESY experiments, water suppression was achieved using a modified WATERGATE sequence (31) . Two-dimensional spectra were generally collected over 4096 data points in the f2 dimension and 512 increments in the f1 dimension over a spectral width corresponding to 12 ppm. For identification of slowly exchanging amides, a series of one-dimensional and TOCSY spectra were run immediately after dissolving the sample in D 2 O. All spectra were processed on a Silicon Graphics workstation using XWINNMR (Bruker). The f1 dimension was zero-filled to 2048 real data points with the f1 and f2 dimensions being multiplied by a sine-squared function shifted by 90°prior to Fourier transformation. Processed spectra were analyzed and assigned using the program XEASY (32). Spectra were assigned using the sequential assignment protocol (33) . The process was facilitated, in part, Mutated residues are marked in gray. Selectivity determined from oocyte studies except for EpI, which was determined from studies in neurons.
using the automatic assignment program NOAH, which is part of the DYANA package (34) .
Structure Calculations-Cross-peaks in NOESY spectra recorded in 90% H 2 O, 10% D 2 O with mixing times of 350 and 150 ms were integrated and calibrated in XEASY, and distance constraints were derived using DYANA. Backbone dihedral angle restraints were derived from 3 J HNH␣ coupling constants measured from line shape analysis of antiphase cross-peak splitting in the DQF-COSY spectrum. Angles were restrained to Ϫ120°Ϯ 30 for 3 J HNH␣ Ͼ 8.5 Hz and to Ϫ60°Ϯ 30 for 3 J HNH␣ Ͻ 5 Hz. Stereospecific assignments of ␤-methylene protons and 1 dihedral angles were derived from 3 J␣␤ coupling constants, measured from ECOSY spectra, in combination with NOE peak intensities (35) . Slowly exchanging amide protons identified by D 2 O exchange experiments were used in conjunction with preliminary structures to determine hydrogen bonds. In cases where hydrogen bonds could be determined and unambiguously assigned, appropriate distance restraints were included in the subsequent calculations. Preliminary structures were calculated using a torsion angle simulated annealing protocol within DYANA. Final structures were calculated using simulated annealing and energy minimization protocols within CNS version 1.0 (36). The starting structures were generated using random , dihedral angles and energy-minimized to produce structures with the correct local geometry. A set of 50 structures was generated by a torsion angle simulated annealing protocol (37, 38) . This protocol involves a high temperature phase comprising 4000 steps of 0.015 ps of torsion angle dynamics, a cooling phase with 4000 steps of 0.015 ps of torsion angle dynamics during which the temperature was lowered to 0 K, and finally an energy minimization phase comprising 5000 steps of Powell minimization. Structures consistent with restraints were subjected to further molecular dynamics and energy minimization in a water shell, as described by Linge and Nilges (39) . The refinement in explicit water involves the following steps. First heating to 500 K via steps of 100 K, each comprising 50 steps of 0.005 ps of Cartesian dynamics. Second, 2500 steps of 0.005 ps of Cartesian dynamics at 500 K before a cooling phase where the temperature was lowered in steps of 100 K, each comprising 2500 steps of 0.005 ps of Cartesian dynamics. Finally, the structures were minimized with 2000 steps of Powell minimization. Structures were analyzed using Promotif and Procheck (40, 41) .
RESULTS
Isolation and Chemical Characterization of GID
Isolation and Sequence of GID-In the search for new ␣-conotoxins, the crude venom of C. geographus was screened for inhibition of agonist-evoked currents at muscle nAChR and different combinations of neuronal nAChR subunits (␣3␤2, ␣3␤4, ␣4␤2, ␣4␤4, and ␣7) heterologously expressed in Xenopus oocytes. Crude venom (50 g protein/ml by BCA assay) caused 100% block of the ␣3␤2 and ␣7 nAChR subtypes and had weak activity at ␣4␤2. LC/MS analysis of the crude venom, and MS analysis of individual fractions, confirmed the presence of the known muscle selective ␣-conotoxins GI, GIA, and GIB, while GII and the neuronally active GIC were not found (Fig. 2, A and  B) . Thus this pool of C. geographus crude venom appeared to contain a novel neuronally active ␣-conotoxin. Inhibitory activity at the ␣3␤2 and ␣7 subtypes was used to guide fractionations of the crude venom, yielding a single component of 2184.9 Da (Fig. 2, A and B) that inhibited ␣3␤2, ␣7, and ␣4␤2 nAChR subtypes. Edman sequencing of the reduced and alkylated peptide, together with mass spectrometry evidence for the ␥-carboxyglutamic acid (␥), revealed a new ␣4/7-conotoxin sequence IRD␥CCSNPACRVNNOHVC (Fig. 1) , that we named ␣-GID following the nomenclature proposed by Olivera and co-workers (8) . The identical sequence was also identified in Conus tulipa crude venom. 2 GID possesses an NN(P/O) motif also found in ␣-conotoxins EpI, PnIA, and PnIB (Fig. 1A ) but additionally has a four residue N-terminal tail. GID is the first non-amidated, neuronally active ␣-conotoxin identified.
Chemical Synthesis of GID and Analogues-To characterize GID and investigate the influence of the N-terminal tail on its functional properties, GID and an analogue missing the four N-terminal amino acids (GID⌬1-4) were synthesized (Fig. 1B) . A single point mutant, [R12A]GID, was also synthesized to investigate the influence of the unusual charged residue in this position on nAChR selectivity. All peptides were purified to Ͼ95% purity determined by HPLC and MS analysis. Oxidized synthetic GID co-eluted with native GID on reversed-phase HPLC (Fig. 2C) , and both peptides had identical masses (monoisotopic masses: observed native, 2184.9; observed synthetic, 2184.9; theoretical, 2184.9).
Functional Characterization of GID-Both native and synthetic GID blocked ␣3␤2 and ␣7 nAChRs receptors expressed in Xenopus oocytes with equal potency (data not shown). Synthetic GID was used in further experiments to determine the potency and subtype selectivity of GID at neuronal ␣3␤2, ␣3␤4, ␣4␤2, ␣4␤4, and ␣7, and muscle ␣1␤2␥␦ nAChRs expressed in oocytes. The concentration response curves for GID are shown in Fig. 4A , and IC 50 values and Hill slope coefficients are summarized in Table I . GID was most potent at ␣3␤2 and ␣7 nAChR subtypes, with IC 50 values of 3 and 5 nM, respectively (Fig. 3A) . The activity at the ␣3␤4, ␣4␤4, and muscle nAChRs was at least 1000-fold less. This potency and selectivity profile of GID is somewhat reminiscent of ␣-conotoxin PnIA and [A10L]PnIA (42, 43) . In contrast to these peptides, however, GID also showed activity at the ␣4␤2 subtype (IC 50 150 nM). Despite several sequence similarities in the second loop, no ␣4␤2 activity was found for [A10L]PnIA (42) at 3 M (Fig. 3B) .
Influence of the N-terminal Tail and Arg 12 on Subtype Selectivity-To identify which structural determinants contribute to GID selectivity, the roles of the N-terminal tail and the basic residue Arg 12 were investigated. Deletion of the four N-termi-2 L. Thomas and R. J. Lewis, unpublished data.
FIG. 2. Isolation and synthesis of ␣-GID. A, total ion chromatogram of C. geographus crude venom extract. The arrow indicates ␣-GID.
A reconstructed molecular mass spectrum of GID is shown in the inset. B, purification of GID by HPLC. C, coelution of native and synthetic GID. Synthetic GID (sGID) and native (nGID) were co-injected in a 2:1 ratio and analyzed by HPLC. Retention time (38.3 min) and peak width was the same for synthetic, native, and the co-injected peptides.
nal amino acids of GID reduced the activity of the peptide at the ␣4␤2 combination by ϳ4-fold (Fig. 3B) . Interestingly, GID⌬1-4 (1-10 M) caused only a partial block (ϳ40%) of ␣4␤2 receptors, indicating that the tail of GID was required for full antagonist activity at this subtype combination (no partial agonist activity was detected with this truncated analogue, data not shown). However, potency at the ␣7 and ␣3␤2 subtypes was little influenced by removal of the four N-terminal residues. Activity of [R12A]GID at the ␣4␤2 and ␣7 subtype was reduced ϳ10-fold compared with GID, whereas activity at the ␣3␤2 subtype was little affected (Fig. 3, B-D ). An analogue in which the four N-terminal amino acid residues of [R12A]GID were removed ([R12A]GID⌬1-4) did not cause any inhibition of the ␣4␤2 receptor at 3 M (data not shown).
Influence of the N-terminal Sequence on the Off-rate Kinetics-Inhibition of the ␣4␤2 nAChR by GID and its analogues was rapidly reversible, with at least 90% recovery of responses seen after 2 min (data not shown). However, recovery of the ␣3␤2 and ␣7 subtypes from GID block was significantly slower, requiring 10 and 15 min, respectively (Fig. 4, A and C) . In contrast, inhibition of both ␣3␤2 and ␣7 receptors by GID⌬1-4 was reversed after a Ͻ2-min washout (Fig. 4, B and D) . Recovery from block by [A10L]PnIA, which does not have an Nterminal tail, was rapid at the ␣3␤2 subtype but slow at the ␣7 subtype (data not shown).
Structural Characterization of GID
NMR Assignments-All spectral data on GID were recorded in either 90% H 2 O, 10% D 2 O or 100% D 2 O. Spectra recorded at 287 K were primarily used for assignments, while spectra measured at other temperatures were used to resolve ambiguities.
Structure Determination and Analysis-Analysis of the 350-ms NOESY spectrum (750 MHz, 287 K) using the program XEASY allowed the assignment of each spin system to a specific amino acid. All non-intraresidual peaks were subsequently assigned both manually and using the NOAH automatic assignment within the DYANA program package. Interproton distance restraints were derived from the NOE intensities and used in structure calculations using a torsion angle simulated annealing protocol within DYANA. Preliminary structures were analyzed to resolve spectral ambiguities and to facilitate the introduction of new restraints. A set of restraints consisting of 183 NOE-derived distances and 15 dihedral angle restraints was used in the final calculations. These restraints included 82 sequential, 35 medium range, 10 long range, and 56 intraresidue distances, 6 19 ). Side-chain angle restraints were derived on the basis of coupling constants and NOE intensities from a 150 ms NOESY spectrum. There were also four restraints included for two hydrogen bonds identified in preliminary structures. In the final round of structure calculations, these restraints were used to calculate a family of 50 structures, using a torsion angle simulated annealing (37, 38) protocol within CNS version 1.0 (36). Structures consistent with the restraints were subjected to further molecular dynamics and energy minimization in a water shell.
Secondary Structure-The differences between the H␣ chemical shifts of GID and random coil values (44) are shown in Fig.  5 . A negative secondary shift (upfield) for several residues indicates that GID contains helical structural elements. The longest uninterrupted region of negative secondary shifts is Table I. observed for residues 9 -13, suggesting that this region forms a well-defined helix.
Disulfide Connectivity-The amino acid sequence of GID includes four cysteine residues that are involved in two disulfide bonds. Initially, the connectivities of the disulfide bonds were unknown but were assumed to be identical to PnIA on the basis of sequence similarities. Thus, the pairing of the disulfides was assumed to be 5-11 and 6 -19 (the globular conformation). To test the validity of this assumption, in addition to calculations with the globular connectivity, structures were calculated with the other two possible disulfide connectivities, 5-6, 11-19 (beads conformation), and 5-19, 6 -11 (ribbon conformation). The resultant structures for the beads and ribbon isomers clearly violated the experimental data with the average target function from DYANA significantly higher than observed for the globular conformation. The beads and ribbon conformations had target functions of 17.45 and 13.44, respectively, compared with 0.16 for the globular conformation. Structures were also calculated without S-S restraints, and the average target function was 6.94. Analysis of the S-S distances in these structures revealed Cys 5 -Cys 11 was the most likely connectivity. The next most likely bond was between Cys 6 -Cys 19 ; however, the distance between Cys 5 -Cys 19 was not significantly different. In summary, the structure calculations with and without the disulfide bonds confirmed that GID adopted the globular conformation, and thus had the same disulfide bond pairings as other ␣-conotoxins.
Description of the Three Dimensional Structure of GID-A family of the 20 lowest NOE energy structures was chosen from the final set of 50 structures to represent the solution structure of GID. The statistics for these 20 structures, which had no distance violations greater than 0.2 Å and no dihedral angle violations greater than 3.0°, are given in Table II . The structures were well defined with the exception of the N-terminal tail, which had few experimental restraints defining this region. The mean RMSD over residues 4 -19 was 0.34 Ϯ 0.17 Å for the backbone atoms and 1.43 Ϯ 0.32 Å for the heavy atoms. The family of structures obtained superimposed over the backbone atoms of residues 4 -19 is shown in Fig. 6A . The ribbon representation of the lowest energy structure is shown in Fig.  6B . Analysis of the backbone angles reveals that 85% of the residues lie in the most favorable regions of the Ramachandran plot, 14% are in the additionally allowed region, 0.5% in the generously allowed region, and 0.5% in the disallowed region. The residues in the generously allowed and the disallowed regions correspond to Asp 3 and Ile 1 , respectively, both in the poorly defined N-terminal tail.
The solution structure of GID was determined to be a highly compact globular structure consisting of a central region of ␣-helix and ␤-turns at both the N and C termini. The ␣-helix comprises residues 9 -13 and has two turns. H-bonds between Asn 8 (O)-Cys 11 (HN) and Pro 9 (O)-Val 13 (HN) were deduced from analysis of preliminary structures and slow exchange data and were explicitly included in the structure calculations. At the N terminus, the poor definition of residues 1-3 may be associated with flexibility of this region in solution. Analysis with PRO-MOTIF reveals that residues 5-8 are involved in a type I ␤-turn, while residues 15-18 are involved in a type II ␤-turn in 7 of 20 final structures.
A surface representation of GID illustrates a distinct hydrophobic face (Fig. 7A) (A and B) or ␣7 (C and D) nAChR subtypes were stimulated with 1-s pulses of ACh or nicotine (in the case of ␣7) applied at 2-min intervals. Oocytes were first perfused for one more minute with ND96 solution, then incubated with toxin for 1 min in a static bath, before recommencing agonist applications during superfusion. Experiments were repeated three times with similar results. Note that at short incubation times GID is less potent than GID⌬1-4, indicating that removal of the N-terminal tail increased on-rate kinetics as well as accelerating the off-rate kinetics. tail. The fourth (Arg 12 ) is situated adjacent to the hydrophobic face.
DISCUSSION
Using functional nAChR assay-guided fractionation, we isolated ␣-conotoxin GID from the crude venom of C. geographus. ␣-GID is the sixth ␣-conotoxin and the second neuronally active ␣-conotoxin isolated from this species (8, 45) , showing the importance of ␣-conotoxins targeting both muscle and neuronal nAChRs for prey capture. GID appears to replace GIC in this pool of C. geographus venom. The sequence of GID differs from previously described ␣-conotoxins in a number of regards. The most striking is the novel N-terminal tail comprising four amino acids (Ile 1 , Arg 2 , Asp 3 , Gla 4 ) including the post-translationally modified ␥-carboxyglutamic acid (Gla). An examination of the pre-pro regions of ␣-conotoxins from the SWISS-PROT data base reveals that most conopeptide precursor sequences contain Arg-Arg, Lys-Lys, Gln-Arg, Lys-Arg, or ArgAsp motifs as the cleavage site. For example, ImIIA utilizes Ile-Arg-Asp-Tyr (accession number Q9U619) to leave a Tyr at position 1 in the mature conopeptide. Since the Arg-Asp cleavage site is not utilized in GID, it appears that the ␥-carboxylation of Glu4 in GID inhibits this cleavage site, allowing the N-terminal tail to survive in the venom. GID is the first ␣-conotoxin to utilize a hydroxyproline residue, despite its widespread use in other classes of conotoxins, and is the first neuronally active ␣-conotoxin with a non-amidated C terminus.
Several neuronally active ␣-conotoxins have been identified that have nanomolar potency for only the ␣3␤2 (MII, GIC), ␣3␤4 (AuIB), or ␣7 (ImI) receptors expressed in Xenopus oo- 
FIG. 7. Comparison of the surfaces of ␣-GID (A) and PnIA (B).
Two orientations (rotated 180°around the y-axis) are shown for each molecule superimposed over the ␣-helical residues. Negatively and positively charged residues are shown in red and blue, respectively (the His is assumed to be uncharged at physiological pH). Hydrophobic residues are shown in green, and hydrophilic residues are in gray. Cysteine residues involved in disulfide bonds are shown in yellow. Note a common hydrophobic patch comprising Pro 6 cytes (10, 45, 46, 47) (Fig. 1) . Other ␣-conotoxins such as PnIA and PnIB inhibit both the ␣7 and ␣3␤2 subtypes with nanomolar potencies, with PnIA being ␣3␤2 selective and PnIB being ␣7 selective (42, 43) . GID also has low nanomolar potency at these two nAChR subtypes, but additionally targets the ␣4␤2 receptor at nanomolar levels. Thus GID has structural features that allow it to recognize a broader range of nAChR binding sites than other ␣-conotoxins, making it a versatile tool for structure-activity studies at the ACh binding site. Comparison of its structure with those of more "specialized" ␣-conotoxins may reveal the critical determinants for subtype selectivity. The ACh binding site has been localized at the interface of an ␣-subunit (ϩ face) and the respective non-␣ subunit (or Ϫ face in case of the ␣7 nAChRs) (48 -50) . To date, there is limited information on the binding mode of neuronally active ␣-conotoxins and the factors that determine subtype selectivity. In a study to determine the direct interactions between amino acids of the ␣7 receptor and ␣-conotoxin ImI, Quiram et al. (49) found that the two exposed loops of the peptide interact with different subunits of the ␣7 receptor, thus bridging the interface between two adjacent subunits. However, a similar mode of binding was not found for PnIB (51) . Instead, the key bioactive residues of this peptide form a localized hydrophobic patch that appears to interact mostly with the ϩ face of the ␣7 binding site. Various neuronally active ␣-conotoxins might have evolved that have one or more attachment points and target different microdomains that overlap the ACh binding site on nAChRs (51) . Therefore, it might be useful to further subgroup the neuronally active ␣-conotoxins based on their subunit specificity and sequence similarity in order to compare structures that are likely to have similar binding modes.
The three-dimensional solution structure of ␣-conotoxin GID reveals that it is a well defined molecule, with a backbone RMSD over residues 4 -19 of 0.34 Å; however, residues 1-3 are completely disordered. The side-chains are well defined, with the exception of Arg 2 , Gla 4 , and Arg 12 . The core of the molecule is occupied by the cysteine residue side-chains, whereas the side-chains of the remaining residues are solvent-exposed. The NMR structure of GID was compared with the crystal structure of PnIA (17) , an ␣-conotoxin with the same global fold and related activity at ␣7 and ␣3␤2 (Fig. 7B) . Superimposition of the ␣-helical backbone residues of GID with PnIA gives an RMS deviation of 0.29 Å. This similarity is evidence that ␣4/7-conotoxins utilize the same highly conserved, well-defined backbone structure to present a range of different side-chains for interaction with specific nAChRs.
Charge distribution appears to be an important factor that determines nAChR selectivity, with neuronal specific ␣-conotoxins being neutral or negatively charged, and muscle-specific ␣-conotoxins having a net positive charge (52) . For example, PnIA contains a single negatively charged residue, Asp 14 , which together with a positive N terminus and neutral, amidated C terminus results in a net charge of zero. At physiological pH, GID has four charged residues including two positive (Arg 2 and Arg 12 ) and two negatively charged residues (Asp 3 and Gla 4 ). Combined with balancing positive and negatively charged termini (unlike most other conotoxins GID contains no amidated C terminus) the net charge is close to zero. A comparison of the surfaces of GID and PnIA shows that both molecules have a similar hydrophobic patch on one face of the molecule. This patch includes amino acid residues Pro 6 , Pro 7 , Ala 10 , and Pro 13 in PnIA (Fig. 7B) , and the corresponding residues Pro 9 , Ala 10 , Val 13 , and O 16 in GID (Fig. 7A) . A similar cluster of hydrophobic residues (Leu 5 , Pro 6 , Pro 7 , Ala 9 , and Leu 10 ) has been shown to be important for the high affinity binding of PnIB to the ␣7 receptor (51) . Exchanging Ala with Leu at position 10 in PnIA ([A10L]PnIA) enhanced ␣7 and reduced ␣3␤2 potency, suggesting that a long aliphatic sidechain in this position favored ␣7 selectivity (42, 43) . In support, the ␣4/7-conotoxin GIC has a Gly in position 10 and is a potent ␣3␤2 inhibitor (45) (see Table III ). GID, which has similar potency at both ␣7 and ␣3␤2 receptors, has an intermediate length side-chain (Val 13 ) in the equivalent position to Ala and Leu. Taken together, it appears that the length of the sidechain in position 10 (or position 13 in GID) of these ␣4/7-conotoxins correlates with their selectivity for ␣7 or ␣3␤2 receptors: the longer the aliphatic side-chain the more ␣7-selective and less ␣3␤2-selective the peptides become (Table  III) .
The neighboring amino acid residues in positions 9 and 11 also seem to contribute to this selectivity: Arg 12 of GID (equivalent to Ala 9 of PnIA), contributes to ␣7 selectivity, since replacing it with an Ala reduced ␣7 activity by 10-fold without affecting activity at the ␣3␤2 receptor. In contrast, Asn 11 may contribute more to ␣3␤2 versus ␣7 selectivity, since [N11S]PnIA was 24-fold less active at the ␣3␤2 combination but only 7-fold less active at the ␣7 subtype as compared with PnIA. Likewise, PnIB, which has a Ser in position 11, was ϳ20-fold less active at ␣3␤2 receptors but only 5-fold less active at the ␣7 nAChR than [A10L]PnIA (43) . Activity at ␣7 was little altered in the Asn12Ala and Pro13Hyp analogues of PnIB (51) . However, their conservation in most ␣4/7-conotoxins suggests they have evolved as a structurally important motif. As positions 14 and 15 in PnIB also had little influence on affinity (51), it appears that the side-chains of the first three N-terminal residues in loop II of these ␣4/7-conotoxins play a key role in determining potency and selectivity at ␣3␤2 and ␣7 subtypes.
GID contains a unique N-terminal tail comprising four amino acids. Removal of these residues did not affect activity at ␣7 and ␣3␤2 subtypes but strongly reduced block at the ␣4␤2 subtype, turning GID into a partial inhibitor at this receptor. These results suggest that N-terminal residues outside the cysteine framework can contribute to ␣4␤2 activity. However, this N-terminal motif is not essential for full inhibition of ␣4␤2, since GIC is a full inhibitor of the ␣4␤2 receptor with an IC 50 value of 300 nM (45) . The reduced times to washout of GID⌬1-4 from the ␣7 and ␣3␤2 receptors suggest that the N-terminal CALSNP (43) tail can stabilize the binding of GID to ␣7 and ␣3␤2 receptors, presumably by interacting with residues near the ACh binding pocket that are not accessible to smaller ␣-conotoxins. The reduced activity of [R12A]GID at the ␣4␤2 receptor indicates that Arg 12 in loop II also contributes to GID block of ␣4␤2. Thus GID reveals novel features contributing to ␣-conotoxin binding to the ␣4␤2 receptor. Improving the structural stability of the N-terminal tail in GID or adding it to other ␣-conotoxins provides new avenues for the development of ␣4␤2 selective inhibitors.
